A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity

Abroad (travel likely)RecruitingPHASE1

Conditions

Overweight · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Parexel International GmbH, Berlin, Germany

Study leads

Clinical Transparency' (dept. 2834)
Study Director
Novo Nordisk A/S

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

Obesity and Overweight

Abroad (travel likely)Recruiting

Birmingham, United States

Impact of Microbiome-changing Interventions on Food Decision-making

Overweight and Obesity

Abroad (travel likely)Recruiting

Leipzig, Germany

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Daphne, United States · Fairhope, United States

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States